News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
128 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21549)
Month
January (2721)
February (3480)
March (4381)
April (4039)
May (4871)
June (4841)
July (3188)
August (2609)
September (3140)
October (3520)
November (2936)
December (2392)
Day
1 (128)
2 (168)
3 (171)
4 (129)
8 (180)
9 (169)
10 (144)
11 (120)
14 (176)
15 (174)
16 (163)
17 (142)
18 (101)
21 (166)
22 (158)
23 (131)
24 (131)
25 (106)
28 (125)
29 (170)
30 (188)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
Drug Development
Kowa Company: LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
September 1, 2009
·
3 min read
Drug Development
ACADIA Pharmaceuticals, Inc., Biovail Corporation’s Psychosis Drug Misses Primary Goal
September 1, 2009
·
5 min read
Drug Development
Antisoma PLC: Phase III Trial Of ASA404 In Lung Cancer Completes Patient Enrollment
September 1, 2009
·
4 min read
Business
Medtronic, Inc. (JOBS) Looks Outside for Heart Division Chief; Consolidates Businesses Into Two Groups
September 1, 2009
·
2 min read
Deals
ICU Medical, Inc. Closes Purchase of Hospira, Inc.'s Critical Care Product Line
September 1, 2009
·
1 min read
Pharm Country
Prof. Offen to Discuss Latest Progress of BrainStorm Cell Therapeutics Inc. Today on Israeli National Radio
September 1, 2009
·
1 min read
Drug Development
Novavax, Inc. Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate; NVAX Shares Rise
September 1, 2009
·
7 min read
Lone Star Bio
Cancer Prevention and Research Institute of Texas Announces Release of Five Initial Research Funding Opportunities
September 1, 2009
·
1 min read
Pharm Country
CardioNet, Inc. Provides Update on Communications with Highmark Medicare Services Regarding Mobile Cardiovascular Technology Reimbursement
September 1, 2009
·
1 min read
Business
Ceragenix Pharmaceuticals, Inc. Release: Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application
September 1, 2009
·
1 min read
Previous
5 of 13
Next
